Aug 3, 2026 06:35AM
Jul 14, 2026 08:30AM
Jul 14, 2026 08:30AM
May 5, 2026 04:05PM
Apr 20, 2026 05:00PM
Apr 20, 2026 05:00PM
Feb 24, 2026 04:05PM Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
Feb 17, 2026 08:30AM
Feb 9, 2026 11:15AM
Feb 9, 2026 11:14AM
Dec 22, 2025 07:06AM
Dec 9, 2025 07:00AM
Oct 24, 2025 08:29AM
Sep 17, 2025 04:30PM Biogen gets European approval for postpartum depression treatment
Sep 17, 2025 04:30PM
Jul 31, 2025 08:44AM
Jul 31, 2025 08:44AM
Jun 17, 2025 06:42AM
Jun 16, 2025 07:01AM
Jun 16, 2025 07:00AM
May 29, 2025 08:30AM Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals
May 28, 2025 04:05PM
May 20, 2025 08:30AM
Feb 25, 2025 04:01PM
Feb 4, 2025 11:28AM
Feb 4, 2025 11:19AM
Feb 4, 2025 09:02AM
Feb 4, 2025 09:00AM Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
Jan 27, 2025 08:00AM
Jan 27, 2025 08:00AM
Jan 27, 2025 08:00AM
Nov 4, 2024 04:05PM
Sep 24, 2024 07:30AM
Aug 19, 2024 07:01AM
Aug 19, 2024 07:00AM Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
Aug 1, 2024 04:30PM
May 23, 2024 04:06PM
May 23, 2024 04:05PM
May 8, 2024 04:05PM
May 7, 2024 10:01AM
May 7, 2024 10:00AM
Apr 8, 2024 10:10AM Jefferies on Supernus (SUPN): 'We expect a -5-10% stock reaction after the FDA's rejection of SPN-830'
Apr 8, 2024 10:09AM
Apr 8, 2024 08:05AM
Apr 8, 2024 08:00AM
Feb 27, 2024 04:05PM
Feb 5, 2024 08:31AM
Feb 5, 2024 08:30AM
Nov 8, 2023 04:05PM Supernus Announces Third Quarter 2023 Financial Results
Nov 2, 2023 07:06AM

327,859 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All